Abstract

Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein activities. Proteins in the form of complexes have a ubiquitous role in diverse range of cellular functions. The key challenge is to identify novel disease associated protein complexes and their potential role in the progression of AD pathology. Protein complexes were obtained from AD brain prefrontal cortex and age matched controls by Blue Native-Polyacrylamide Gel Electrophoresis. A proteomic analysis was performed using second dimension SDS-PAGE followed by nano LC–MS/MS. Differentially expressed proteins were mapped to existing biological networks by Ingenuity Pathway Analysis (IPA). A total of 13 protein complexes with their interacting proteins were resolved on SDS-PAGE. We identified 34 protein spots and found significant abundance difference between the two experimental samples. IPA analysis revealed degeneration of neurons and cell death as a major consequence of protein dysregulation. Furthermore, focused network analysis suggested an integrated regulation of the identified proteins through APP and MAPT dependent mechanisms. The interacting differentially expressed proteins in AD were found to be part of concomitant signaling cascades terminating in neuronal cell death. The identified protein networks and pathways warrant further research to study their actual contribution to AD pathology.

Highlights

  • Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein activities

  • Significant decrease was observed in the expression level of complex IV comprised of immunoglobulin super family member 8 (IGSF8) and microsomal glutathione S transferase (MGST1) along with complex XIII comprised syntaxin-1A (STX1A) and tubulin polymerization promoting protein (TPPP) in AD brain as compared to control samples

  • A total of 117 protein spots were detected, when the aggregates of Blue Native-Polyacrylamide Gel Electrophoresis (BN-PAGE) derived protein complexes were resolved on 12.5–7.5% SDS-PAGE

Read more

Summary

Introduction

Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein activities. Aggregates of intraneuronal neurofibrillary tangles (NFTs) and extracellular β-amyloid (Aβ) plaques are the hallmarks of Alzheimer’s disease (AD)[1] Their specific roles in etiology or pathology of AD have been extensively studied, the mechanism by which these structures in association with other molecular factors contribute to neuropathology remains ­elusive[2]. The potential biological role of a protein in an orchestrated cellular environment can be inferred from its protein–protein interaction (PPI) n­ etwork[4]. The data of human protein–protein interactions (PPIs) brought insights to the network biology of diseases and explained the inter-relationships among disease-related genes and ­proteins[5] Multiple proteins and their networks are altered in AD which results in altering the overall physiological state of the ­cell[1]. Pathways and potential therapies against diseases using PPI d­ ataset[6], interacting proteins and their networks in AD are still elusive

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call